Novel SupremeTM DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation after DES implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2021 at "Circulation"
DOI: 10.1161/circulationaha.120.052482
Abstract: Background: Accelerated endothelial healing after targeted antiproliferative drug delivery may limit the long-term inflammatory response of drug eluting stents (DES). The novel SupremeTM DES (Supreme) is designed to synchronize early drug delivery within 4-6 weeks… read more here.
Keywords: drug delivery; supreme des; trial; supreme ... See more keywords